From: Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers
Samples | Cell Lines | Drug/ phytotherapy | Dose range | Target | Pathway | Function | Refs. |
---|---|---|---|---|---|---|---|
– | SCC-4, SCC-9, SCC-25, FaDu, UM-SCC-22A | Chloroquine (CQ) | 0–30 µM | MAP1LC3B, SQSTM1 | PI3K/AKT, mTOR | PI3K/AKT/mTOR autophagy pathway could be blocked by CQ that had an inhibitory effect on HNSCC proliferation | [43] |
114 pairs of HNSCC and adjacent normal tissues | FaDu, Cal-27, SCC4, SCC9, HaCaT | – | – | RNA FKBP9P1 | PI3K/AKT | Silencing expression of RNA FKBP9P1 via PI3K/AKT signaling pathway can constrain the progression of HNSCC | [38] |
– | Fadu, SSC-9, SSC-25, OSC-19, Cal-27, HOK | – | – | Profilin 2 (PFN-2), GSK-3β, β-catenin | PI3K/AKT | PFN2 via activating the PI3K/AKT/β-catenin pathway could promote the proliferation and metastasis of HNSCC | [39] |
– | FaDu, Cal27, SCC25, HN4 | Osthole | 0–240 µM | PTEN, Cdc2, Cyclin-B1, Bcl-2, Bax, PARP1, Survivin, Caspase3/9 | PI3K/AKT | Osthole via suppressing the PI3K/AKT pathway could have an anti-tumor effect on HNSCC | [41] |
Male BALB/cAJcl-nu/nu nude mice | HSC-3 shDKK3, HSC-3 shScr | – | – | DKK3, β-catenin, GSK-3β, p55, PDK1, p38, TGF-β | PI3K/AKT, mTOR, MAPK | DKK3 via the PI3K/AKT/mTOR and MAPK pathways could increase the malignant properties of HNSCC | [40] |
Female BALB/C nude, HNSCC (n = 298), NCLM (n = 98) | FaDu, 293 T, AMC-HN-8, Tca-8113, Cal-27 | – | – | STC2, Snail, Vimentin, E-cadherin | PI3K/AKT | STC2 via the PI3K/AKT/Snail pathway can promote HNSCC metastasis, proliferation, and tumoral cell growths | [44] |
– | OSC-20, HEEC, SNU-1076, HSC-3, Ca9-22 | – | – | HPIP | PI3K/AKT | Knockdown of HPIP via suppressing the PI3K/AKT pathway can inhibit invasion, proliferation, and invasion of HNSCC | [45] |
HNSCC (n = 36), Female C57BL/6 mice | PBMC, TIL | – | – | Tim-3 | PI3K/AKT | Adaptive resistance to anti-programmed death-1 (PD1) therapy through up-regulating Tim-3 could be mediated via the PI3K/AKT pathway | [42] |
HNSCC (n = 36) | Tu686, 5-8F | – | – | Metadherin (MTDH), VEGF | PI3K/AKT | MTDH could regulate VEGF expression via the PI3K/AKT pathway, resulting in HNSCC metastasis and angiogenesis | [46] |